Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H27F3N4O3 |
Molecular Weight | 464.4807 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)CC2=C(C(=NN2C3=CC=C(C(N)=O)C(N[C@H]4CC[C@H](O)CC4)=C3)C(F)(F)F)C(=O)C1
InChI
InChIKey=ZFVRYNYOPQZKDG-MQMHXKEQSA-N
InChI=1S/C23H27F3N4O3/c1-22(2)10-17-19(18(32)11-22)20(23(24,25)26)29-30(17)13-5-8-15(21(27)33)16(9-13)28-12-3-6-14(31)7-4-12/h5,8-9,12,14,28,31H,3-4,6-7,10-11H2,1-2H3,(H2,27,33)/t12-,14-
SNX-2112, a novel 2-aminobenzamide inhibitor of heat shock protein 90 (Hsp90) was discovered by Serenex. This drug was investigated for treatment of different cancer cell lines, including hepatocellular carcinoma cells, breast cancer cells and in combination with 5-fluorouracil in esophageal cancer. However, subsequent development has been discontinued due to ocular toxicity as identified in a phase I study.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095165 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18172276 |
30.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18172276
Treatment of BT-474 cells with 1 μM SNX-2112 results in down-regulation of HER2 expression. Treatment with SNX-2112 also results in a decline in total Akt expression. SNX-2112 inhibits cell proliferation with IC50 values ranging from 10 to 50 nM, in BT474, SKBR-3, SKOV-3, MDA-468, MCF-7 and H1650 cancer cells. And these antiproliferative effects are associated with hypophosphorylation of Rb, arrest of G1 and modest levels of apotosis.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
908112-43-6
Created by
admin on Sat Dec 16 02:44:31 GMT 2023 , Edited by admin on Sat Dec 16 02:44:31 GMT 2023
|
PRIMARY | |||
|
24772860
Created by
admin on Sat Dec 16 02:44:31 GMT 2023 , Edited by admin on Sat Dec 16 02:44:31 GMT 2023
|
PRIMARY | |||
|
10C9P3FFOW
Created by
admin on Sat Dec 16 02:44:31 GMT 2023 , Edited by admin on Sat Dec 16 02:44:31 GMT 2023
|
PRIMARY | |||
|
DTXSID601025695
Created by
admin on Sat Dec 16 02:44:31 GMT 2023 , Edited by admin on Sat Dec 16 02:44:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY